Multiple sclerosis drug slows brain shrinkage, study finds

Results from a clinical trial of more than 250 participants with progressive multiple sclerosis (MS) revealed that ibudilast was better than a placebo in slowing down brain shrinkage. The study also showed that the main side effects of ibudilast were gastrointestinal and headaches.

from Top Health News -- ScienceDaily https://ift.tt/2LEcAkn